Nitrous Oxyde Misuse Among Teenagers Consulting in an Addictology Center Dedicated to Young Drug Users in Montpellier

Last updated: November 23, 2020
Sponsor: University Hospital, Montpellier
Overall Status: Completed

Phase

N/A

Condition

Stimulant Use Disorder

Opioid Use Disorder

Addictions

Treatment

N/A

Clinical Study ID

NCT04301024
RECHMPL20_0116
  • Ages 10-25
  • All Genders

Study Summary

Nitrous oxide gas is used in several application areas : medical as an anesthetic drug ; in food industry as a foaming and a mixing agent ; industrial to speed combustion. It is also misused for its hilarant, euphoric and hallucinogenic effect. For this purpose the gas is transfered in a balloon to be inhaled.

As its effects are briefs, its consumption is often perseived as safe. However, some risks exist and are majorated by the way of use and for some groups of people.

Since 2016, the French observatory of drug and substances addiction (OFDT) describes an increasing misuse of nitrous oxide amoung teenagers and young adults. In november 2019, a french press release alerts on the recent increasing of neurologic side effects related to the misuse of nitrous oxide.

That's why, it seems to be interesting to improve the screening of nitrous oxide abuse, in particular amoung adolescents and young adults.

In our study, the investigators would like to determine the characteristics (social, medical, any drug abuse) of teenagers and young adults who misuse nitrous oxide. Through a questionnaire, the investigators plan to select teenagers and young adults who consult in an addictology center dedicated to young drug consumers in Montpellier. This questionnaire is anonymous. The data will be collected only after obtaining the patient's agreement.

The final goal is to create a tool to help general practitioners in screening young people at risk of nitrous oxyde misuse.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • teenagers and young adults consulting in an addictology center dedicated to young abusersin Montpellier and who agree with being included in the study

Exclusion

Exclusion criteria:

  • to refuse to participate to the study

Study Design

Total Participants: 60
Study Start date:
March 30, 2020
Estimated Completion Date:
September 30, 2020

Connect with a study center

  • Uhmontpellier

    Montpellier, 34295
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.